Respiro 270

Mid-size comfort optiondual control valves3 large windows84 lbs total weight

Description on file

Stored directory description. It is not a test we ran of this chamber.

The Respiro 270 is OxyHealth's mid-size portable chamber, offering a step up in comfort from the Solace 210 with its 27-inch diameter. At 88 inches long, it provides a comfortable lying position for one adult. Features include three large viewing windows, dual control valve technology for both physician-administered and self-treatment, and the same medical-grade construction as all OxyHealth chambers. The 84-lb total system weight makes it portable enough for travel while providing noticeably more interior space.

Who is this for?

A strong fit for dedicated athletes, fitness enthusiasts, and active individuals who want hyperbaric oxygen therapy integrated into their recovery routine. Whether you're managing a sports injury, recovering from a hard training block, or simply optimizing post-workout recovery, the Respiro 270 provides reliable, repeatable sessions at 1.3 ATA at home or in a clinic setting. Athletes who build HBOT into their weekly routine consistently report faster recovery, reduced soreness, and better sleep — this chamber makes that sustainable.

Who it suits

Respiro 270 is a soft-shell chamber, listed at 1.3 ATA, in the $10,000–$25,000 listed-price band, with a listed capacity of 1-person, listed interior size 88in L x 27in dia.

The listing describes who it is for as: A strong fit for dedicated athletes, fitness enthusiasts, and active individuals who want hyperbaric oxygen therapy integrated into their recovery routine. Whether you're managing a sports injury, recovering from a hard training block, or simply optimizing post-workout recovery, the Respiro 270 provides reliable, repeatable sessions at 1.3 ATA at home or in a clinic setting. Athletes who build HBOT into their weekly routine consistently report faster recovery, reduced soreness, and better sleep — this chamber makes that sustainable.

This is not medical advice. Ask your doctor which pressure and setting fit you.

Who should skip it

Listed maximum pressure is 1.3 ATA. HBOT Finder's chamber guide treats 2.0 ATA as the clinical standard, so this chamber is not for protocols that require 2.0 ATA or higher.
Listed chamber type is soft-shell, so this is not a hard-shell clinical chamber.
The low price estimate is $15,000, so this is not a chamber listed under $10,000.

Estimated Price

$15,000 - $18,000

Refurbished available: $9,000 - $13,000

Financing: 0% APR for up to 18 months via retailers

Among 22 soft-shell chambers with a listed low price in the $10,000–$25,000 band, those low prices run from $10,195 to $23,000. This chamber's listed low price is $15,000.

Calculate ownership cost Request a Quote

We reply the same day.

Contact manufacturer

Closest listed alternatives

Same chamber type and listed-price band. Sorted by how close the listed low price and pressure are.

Chamber	Type	ATA	Listed price	Compare
Newtowne Walk-In	soft-shell	1.3	$15,000 - $22,000	—
ProReset Oasis	soft-shell	1.4	Contact manufacturer	Compare
AHA Fit 18	soft-shell	1.8	$15,000 - $20,000 (estimated)	—

Best-of lists

Home chambers under $25,000 Chambers for athletes

Questions from the listing

What maximum pressure is listed for the Respiro 270?

The Respiro 270 listing shows a maximum pressure of 1.3 ATA.

What price is listed for the Respiro 270?

The listing shows $15,000 - $18,000.

Is the Respiro 270 listed as FDA cleared?

In the HBOT Finder database, FDA clearance for the Respiro 270 is "yes". The listed clearance number is K001409.

What type of chamber is the Respiro 270?

The Respiro 270 is listed as a soft-shell chamber.

What size is listed for the Respiro 270?

The listing gives capacity 1-person and interior dimensions 88in L x 27in dia.

Does this page say whether the Respiro 270 is right for a medical condition?

No. This page only repeats the chamber's listed specifications. Ask your doctor before using hyperbaric oxygen therapy. Condition guides on this site summarize published research and are not personal medical advice.